280 related articles for article (PubMed ID: 9695469)
1. [Correlation in Staphylococcus aureus infections between toxic shock syndrome toxin-1 production and clinical feature].
Kiyota H; Ohishi Y; Onodera S; Miki K; Ueda M
Kansenshogaku Zasshi; 1998 Jun; 72(6):593-8. PubMed ID: 9695469
[TBL] [Abstract][Full Text] [Related]
2. Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains.
Schmitz FJ; MacKenzie CR; Geisel R; Wagner S; Idel H; Verhoef J; Hadding U; Heinz HP
Eur J Epidemiol; 1997 Sep; 13(6):699-708. PubMed ID: 9324218
[TBL] [Abstract][Full Text] [Related]
3. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin.
Bonventre PF; Weckbach L; Harth G; Haidaris C
Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656
[TBL] [Abstract][Full Text] [Related]
4. Induction of interleukin-1 by strains of Staphylococcus aureus from patients with nonmenstrual toxic shock syndrome.
Parsonnet J; Gillis ZA; Pier GB
J Infect Dis; 1986 Jul; 154(1):55-63. PubMed ID: 3486924
[TBL] [Abstract][Full Text] [Related]
5. Latex agglutination test for staphylococcal toxic shock syndrome toxin 1.
Igarashi H; Fujikawa H; Shingaki M; Bergdoll MS
J Clin Microbiol; 1986 Mar; 23(3):509-12. PubMed ID: 3082921
[TBL] [Abstract][Full Text] [Related]
6. [Methicillin resistance, production of toxic shock syndrome toxin-1 and types of enterotoxin, protease and coagulase at vaginal isolates of Staphylococcus aureus].
Arai K; Mitsuta T; Fujita S; Yokota S
Kansenshogaku Zasshi; 1993 Oct; 67(10):1005-10. PubMed ID: 8254212
[TBL] [Abstract][Full Text] [Related]
7. Toxin involvement in methicillin-resistant Staphylococcus aureus enteritis in gastroenterological surgery.
Takesue Y; Yokoyama T; Kodama T; Santou T; Nakamitsu A; Murakami Y; Imamura Y; Miyamoto K; Okita M; Tsumura H
Gastroenterol Jpn; 1991 Dec; 26(6):716-20. PubMed ID: 1765246
[TBL] [Abstract][Full Text] [Related]
8. Risk of developing toxic shock syndrome associated with toxic shock syndrome toxin 1 following nongenital staphylococcal infection.
Jacobson JA; Kasworm E; Daly JA
Rev Infect Dis; 1989; 11 Suppl 1():S8-13. PubMed ID: 2928655
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of antibody to toxic shock syndrome toxin-1 in burn patients.
Park JY; Kim JS; Woo H
Ann Lab Med; 2015 Jan; 35(1):89-93. PubMed ID: 25553286
[TBL] [Abstract][Full Text] [Related]
10. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
[TBL] [Abstract][Full Text] [Related]
11. In vitro studies of toxic shock toxin-1-secreting Staphylococcus aureus and implications for burn care in children.
Laabei M; Young A; Jenkins TA
Pediatr Infect Dis J; 2012 May; 31(5):e73-7. PubMed ID: 22301473
[TBL] [Abstract][Full Text] [Related]
12. Expression of type 8 capsular polysaccharide and production of toxic shock syndrome toxin 1 are associated among vaginal isolates of Staphylococcus aureus.
Lee JC; Liu MJ; Parsonnet J; Arbeit RD
J Clin Microbiol; 1990 Dec; 28(12):2612-5. PubMed ID: 2279990
[TBL] [Abstract][Full Text] [Related]
13. Contribution of toxic shock syndrome toxin-1 to systemic inflammation investigated by a mouse model of cervicovaginal infection with Staphylococcus aureus.
Asano K; Narita K; Hirose S; Nakane A
Med Microbiol Immunol; 2018 Nov; 207(5-6):297-306. PubMed ID: 29980843
[TBL] [Abstract][Full Text] [Related]
14. [A study of virulence factors produced by MRSA strains isolated from blood samples].
Mizukane R; Nakatomi M; Futsuki Y; Araki J; Asai S; Sawatari K; Hirakata Y; Maesaki S; Tomono K; Kohno S
Kansenshogaku Zasshi; 1998 Aug; 72(8):788-93. PubMed ID: 9780580
[TBL] [Abstract][Full Text] [Related]
15. [Effect of arbekacin on the production of toxic shock syndrome toxin 1 by methicillin-resistant Staphylococcus aureus].
Miyata A; Araake M; Ogawa H; Hanaki H; Hiramatsu K
Jpn J Antibiot; 2001 Jul; 54(7):372-81. PubMed ID: 11560056
[TBL] [Abstract][Full Text] [Related]
16. An outbreak of neonatal toxic shock syndrome-like exanthematous disease (NTED) caused by methicillin-resistant Staphylococcus aureus (MRSA) in a neonatal intensive care unit.
Nakano M; Miyazawa H; Kawano Y; Kawagishi M; Torii K; Hasegawa T; Iinuma Y; Ohta M
Microbiol Immunol; 2002; 46(4):277-84. PubMed ID: 12061630
[TBL] [Abstract][Full Text] [Related]
17. Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period.
Takahashi N; Nishida H; Kato H; Imanishi K; Sakata Y; Uchiyama T
Lancet; 1998 May; 351(9116):1614-9. PubMed ID: 9620715
[TBL] [Abstract][Full Text] [Related]
18. Low Level of TSST-1 Antibody in Burn Patients With Toxic Shock Syndrome Caused by Methicillin-Resistant Staphylococcus aureus.
Matsushima A; Kuroki Y; Nakajima S; Sakai T; Kojima H; Ueyama M
J Burn Care Res; 2015; 36(3):e120-4. PubMed ID: 25094005
[TBL] [Abstract][Full Text] [Related]
19. [MRSA infection and toxic shock syndrome in burn patients].
Kato K; Tanaka T
Nihon Rinsho; 1992 May; 50(5):1104-11. PubMed ID: 1507435
[TBL] [Abstract][Full Text] [Related]
20. Detection and quantitation of toxic shock syndrome toxin 1 in vitro and in vivo by noncompetitive enzyme-linked immunosorbent assay.
Rosten PM; Bartlett KH; Chow AW
J Clin Microbiol; 1987 Feb; 25(2):327-32. PubMed ID: 3818927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
